In the course of screening for drugs that suppress the Ca 2ϩ -mediated growth inhibition in a yeast mutant, we found that the metabolite of Fusarium sp. strain YCM1008 inhibited Ca 2ϩ -signaling. A novel pyranopyridone, YCM1008A was isolated from the fermentation broth using HLB column chromatography followed by HPLC, and the structure was elucidated by spectral analysis. YCM1008A suppressed Ca 2ϩ -induced growth inhibition of the Saccharomyces cerevisiae (D zds1D syr1) mutant.
Since the basic cellular functions are fairly well conserved from yeast to mammalian cells, it is possible to use the yeast Saccharomyces cerevisiae as a model microorganism for eukaryotes and a useful tool for drug screening. Cellcycle progression in the G 2 period is specifically blocked by hyperactivation of the Ca 2ϩ -signaling pathway in media with high concentrations of CaCl 2 . Cell-cycle regulation via Ca 2ϩ is affected by two parallel pathways, one is the calcineurin and the other is the Mpk1 MAP kinase cascade [1, 2] . These pathways together activate Swe1 to phosphorylate the Cdc28 cyclin-dependent protein kinase and suppress the transition to the M period of the cellcycle, leading to G 2 arrest [3] . Miyakawa et al. established a screening assay system for drugs that suppress Ca 2ϩ -induced growth inhibition [4] using the Dzds1Dsyr1 yeast mutant. In fact, the calcineurin inhibitors FK-506 and cyclosporin A have been detected in this system, and MAP kinase inhibitors are also expected to be identified in this assay. In the course of this screening, we found that the metabolite of Fusarium sp. strain YCM1008 inhibited the Ca 2ϩ -signaling, and we isolated a novel Ca 2ϩ -signaling inhibitor, YCM1008A. In this paper, we describe its fermentation, isolation, and structure elucidation.
The strain YCM1008 was isolated from a soil sample collected in Indonesia and identified as a fungus, Fusarium sp.
A loopful of the strain YCM1008, grown on agar slant, was inoculated into 50-ml test tubes containing 10 ml of seed medium composed of 3.0% dried mashed potatoes, 10% glucose, and 0.5% yeast extract, in deionized water (pH 7.2 before sterilization). After the inoculated test tubes were incubated for 3 days at 25°C in a reciprocal shaker,
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Fumito Koizumi, Naomi Fukumitsu, Jinrong Zhao, Ruthada Chanklan, Tokichi Miyakawa, Shoko Kawahara, Shin Iwamoto, Makoto Suzuki, Shingo Kakita, Endang S. Rahayu, Seijiro Hosokawa, Kuniaki Tatsuta, Michio Ichimura 3.3 ml of the seed culture was added to a 300-ml Erlenmeyer flask containing 50 ml of the fermentation medium composed of 3.0% sucrose, 2.0% soluble starch, 0.5% Ebios, 1.0% malt extract, 0.5% corn steep liquor, 20% V8 vegetable juice, 0.5% calcium carbonate in deionized water (pH 6.5 before sterilization). Fermentation was carried out for 5 days at 25°C with agitation of 200 rpm.
YCM1008A was purified from mycelia obtained by filtration of fermented broth (300 ml). The mycelia cake was extracted with 300 ml of methanol. The extract was diluted with 1.2 liters of deionized water and added to an HLB column (Waters). After washing the column with 20, 40, 60, 80% methanol, respectively, the active principles were eluted from the column with methanol. The active fraction containing YCM1008A was concentrated in vacuo to yield crude YCM1008A. This concentration was dissolved in methanol and purified by preparative HPLC using a column (ODS HG-5, Develosil) with 70% acetonitrile as elution solvent. Active fractions containing YCM1008A were combined and evaporated, and YCM1008A (1.0 mg) was obtained as pale yellow amorphous powder.
The D zds1 D syr1 cells were suspended at a cell concentration of 1ϫ10 5 cells/ml in soft-agar medium then placed on YPD-agar plates containing 170 mM of CaCl 2 . YCM1008A (3 nmol) dissolved in dimethylsulfoxide was spotted on top of the agar. The growth of Dzds1 Dsyr1 cells was severely inhibited by CaCl 2 . However, numerous microcolonies appeared after 2 days of incubation at 28°C around the spot loaded with YCM1008A, giving rise to a doughnut-like halo with a clear zone in the center (21 mm outside diameter and 7.2 mm inside diameter), thus indicating that YCM1008A inhibited Ca 2ϩ -signaling and that it inhibited cell growth at high concentrations.
Physico-chemical properties of YCM1008A are summarized in Table 1 . The molecular formula was determined by high resolution FAB-MS as C 21 H 29 NO 4 . The 13 C-NMR spectrum ( (Fig. 1 ) revealed presence of three partial structures shown in Fig.  2 . Furthermore, HMBC spectrum exhibited long-range correlation: from H-1Ј to C2 (d 84.9) and from H-2 to C1Ј (d 11.4) and C3Ј (d 132.4), indicating connection between the partial structures I and II. Configurations of the three double bonds in the acyl side chain of partial structure I were determined on the basis of coupling constants and NOE experiment. The coupling constants (11 or 15 Hz) of H-4Ј, H-5Ј, H-6Ј, and H-7Ј and NOE data between H-1Ј and H-4Ј, H-3Ј and H-5Ј, H-4Ј and H-6Ј, H-5Ј and H-7Ј, and H-6Ј and H-8Ј showed that the three double bonds in partial structure I have the E-isomer. The coupling constant (7.9 Hz) of H-7 and H-8 showed that the double bond in partial structure III has the Z-isomer.
The HMBC spectrum exhibited long range correlations from H-7 to C5 (d 160. with these carbons and partial structure III. NOE data between H-10 methoxy proton and H-7, absence of long range correlation from H-10 methoxy proton to H-7, and the chemical shift of C7 carbon (136.4 ppm) and C5 carbon (160.8 ppm) indicated these carbons were attached to the Nmethoxy group. The long range correlations from H-4 to C4a and C5 show the connection between the partial structures II and III, and the chemical shifts of C2 carbon (84.9 ppm) and C8a carbon (163.8 ppm) indicate they are attached to oxygen forming a 6-membered ether ring system. Finally, detailed analysis of the HMBC and NOE spectrum, and taking account of the above three partial structures revealed the planar structure of YCM1008A as described in Fig. 1 . The relative configuration of the 6-membered ether ring in YCM1008A was determined by coupling constants and NOE experiment as shown in Fig. 1 . Observation of NOEs between H-4 and H-3, H-3 and H-9, H-4 and H-9, H-2 and H-9, and in addition a large coupling constant between H-2 and H-3 (Jϭ11 Hz) indicated that H-2 and H-3 were of 1,2-diaxial orientation and that 9-CH 3 and H-4 were of equatorial orientation. These results reveal the relative configuration of the 6-membered ether group shown in Fig. 3 . By total synthesis, the planar structure and relative configuration of YCM1008A were confirmed, and furthermore the absolute configuration of YCM1008A was also determined as 2R/3R/4S/8ЈR, respectively, as shown in Fig. 3 [5] . The synthetic compound indicated equipotent activity to that of natural product, YCM1008A in the east assay system described above. Namely, YCM1008A (5 nmol) gave a doughnut-like halo (24 mm outside diameter and 12 mm inside diameter) in D zds1 D syr1 mutant (Fig. 4A) . Furthermore, YCM1008A (5 nmol) also afforded a larger doughnut-like halo (30 mm outside diameter and 16 mm inside diameter) in Dzds1 Dsyr1 Dpdr1 Dpdr3 mutant ( 4B). Two homologous genes, PDR1 and PDR3 encode major transcription factors that regulate the expression of various genes that function in the multidrug resistance [6] . Thus, the D zds1 D syr1 D pdr1 D pdr3 quadruplex mutant seems to be hypersensitive to YCM1008A. YCM1008A possesses a unique N-methoxy pyrano-pyridone structure.
